celecoxib has been researched along with 9,10-dimethyl-1,2-benzanthracene in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (62.50) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abou-Issa, H; Alshafie, GA; Harris, RE; Seibert, K | 1 |
| Bol, DK; Dell, J; Fischer, SM; Ho, CP; Kiguchi, K; Klein, R; Muga, S; Pilz, B; Rowley, RB; Swerdel, M | 1 |
| Berger, I; Furstenberger, G; Marks, F; Muller-Decker, K; Neufang, G; Neumann, M | 1 |
| Jang, TJ; Jung, HG; Jung, KH; O, MK | 1 |
| Hashitani, S; Manno, Y; Nishimura, N; Noguchi, K; Sakurai, K; Takaoka, K; Urade, M | 1 |
| Chen, X; Fang, M; Li, N; Sood, S; Sun, Z; Wang, P; Wang, S; Yang, CS | 1 |
| Ajith, T; Babitha, NV; Jacob, J; Sanjay, PS; Subin, JP | 1 |
| Feng, L; Wang, Z | 1 |
| Dai, ZJ; Kang, HF; Liu, XX; Wang, XJ; Xue, FJ; Xue, XH | 2 |
| Aggarwal, R; Agnihotri, N; Kansal, S; Kaur, R; Negi, AK; Sarotra, P; Sharma, G | 1 |
| Bradish, JR; DaSilva-Arnold, SC; Kim, YL; Konger, RL; Mehta, SR; Mohamed, DR; Rashid, BM; Sahu, RP; Warren, SJ; Xu, Z | 1 |
| Agnihotri, N; Bhatnagar, A; Kansal, S; Negi, AK | 1 |
| Agnihotri, N; Bhatnagar, A; Negi, AK | 1 |
| Jiang, W; Kang, Y; Shao, Z; Wang, S; Wen, Q; Xu, C; Zhu, T | 1 |
| Guo, B; Li, YS; Shan, BZ; Sun, XF | 1 |
16 other study(ies) available for celecoxib and 9,10-dimethyl-1,2-benzanthracene
| Article | Year |
|---|---|
Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Body Weight; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Ibuprofen; Isoenzymes; Mammary Neoplasms, Animal; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Substrate Specificity; Sulfonamides | 2000 |
Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Alopecia; Animals; Carcinogens; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Female; Hair Follicle; Humans; Isoenzymes; Male; Membrane Proteins; Mice; Mice, Inbred ICR; Mice, Transgenic; Phenotype; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Skin; Skin Neoplasms; Sulfonamides; Tetradecanoylphorbol Acetate | 2002 |
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenoma; Animals; Carcinogens; Carcinoma, Squamous Cell; Celecoxib; Cocarcinogenesis; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Gene Expression; Isoenzymes; Mice; Mice, Transgenic; Papilloma; Phenotype; Precancerous Conditions; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrazoles; Skin; Skin Neoplasms; Sulfonamides; Tetradecanoylphorbol Acetate | 2002 |
Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Blotting, Western; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Immunohistochemistry; Isoenzymes; Mammary Neoplasms, Experimental; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides | 2002 |
Increased expression of cyclooxygenase (COX)-2 in DMBA-induced hamster cheek pouch carcinogenesis and chemopreventive effect of a selective COX-2 inhibitor celecoxib.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Celecoxib; Cheek; Cricetinae; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Immunoenzyme Techniques; In Situ Nick-End Labeling; Isoenzymes; Male; Mesocricetus; Mouth Neoplasms; Neovascularization, Pathologic; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides | 2004 |
Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Carcinogens; Carcinoma, Squamous Cell; Celecoxib; Cell Transformation, Neoplastic; Chemoprevention; Cricetinae; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Humans; Hydroxyurea; Immunohistochemistry; In Situ Hybridization; Lipoxygenase Inhibitors; Male; Membrane Proteins; Mesocricetus; Mouth Neoplasms; Neoplasms, Experimental; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Up-Regulation | 2005 |
Antimutagenic and anti-oxidant activities of the non-steroidal anti-inflammatory drug celecoxib.
Topics: 2-Acetylaminofluorene; 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antimutagenic Agents; Antioxidants; Celecoxib; Dose-Response Relationship, Drug; Doxorubicin; Free Radical Scavengers; Lipid Peroxidation; Male; Methylnitronitrosoguanidine; Microsomes, Liver; Mutagens; Mutation; Phenylenediamines; Pyrazoles; Rats; Rats, Sprague-Dawley; Salmonella typhimurium; Sodium Azide; Sulfonamides; Superoxides | 2005 |
Chemopreventive effect of celecoxib in oral precancers and cancers.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Carcinogens; Celecoxib; Chemoprevention; Cricetinae; Cyclooxygenase 2 Inhibitors; Disease Progression; Dose-Response Relationship, Drug; Male; Mesocricetus; Mouth Neoplasms; Precancerous Conditions; Pyrazoles; Random Allocation; Sulfonamides; Time Factors; Treatment Outcome | 2006 |
[Chemopreventive effect of tamoxifen combined with celecoxib on DMBA-induced breast cancer in rats].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Drug Administration Routes; Drug Synergism; Female; Mammary Neoplasms, Experimental; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamoxifen | 2006 |
[Chemopreventive effect of celecoxib against DMBA-induced breast cancer and its mechanism].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Down-Regulation; Female; Immunohistochemistry; Mammary Neoplasms, Experimental; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamoxifen; Treatment Outcome; Vascular Endothelial Growth Factor A | 2006 |
Evaluation of the role of oxidative stress in chemopreventive action of fish oil and celecoxib in the initiation phase of 7,12-dimethyl benz(α)anthracene-induced mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Fish Oils; Glutamate Dehydrogenase; Lipid Peroxidation; Lipids; Mammary Neoplasms, Experimental; Mitochondria; N-Acetylneuraminic Acid; Oxidative Stress; Pyrazoles; Rats; Rats, Wistar; Sulfonamides | 2011 |
Spatiotemporal assessments of dermal hyperemia enable accurate prediction of experimental cutaneous carcinogenesis as well as chemopreventive activity.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents; Carcinogens; Celecoxib; Cell Transformation, Neoplastic; Female; Hyperemia; Inflammation; Mice; Optical Imaging; Pyrazoles; Skin; Skin Neoplasms; Sulfonamides; Ultraviolet Rays | 2013 |
Alteration in apoptosis and cell cycle by celecoxib and/or fish oil in 7,12-dimethyl benzene (α) anthracene-induced mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Calcium; Celecoxib; Cell Cycle; Cells, Cultured; Cyclooxygenase 2 Inhibitors; Epithelial Cells; Fatty Acids, Omega-3; Female; Fish Oils; Flow Cytometry; Immunohistochemistry; Keratin-19; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Proto-Oncogene Proteins c-myc; Pyrazoles; Rats; Rats, Wistar; Reactive Oxygen Species; Sulfonamides; Tumor Suppressor Protein p53 | 2013 |
Fish oil augments celecoxib mediated alteration in apoptotic pathway in the initiation phase of 7,12-dimethylbenz(α)anthracene-induced mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; bcl-2-Associated X Protein; Carcinogenesis; Caspase 8; Celecoxib; Cell Separation; Cytochromes c; Epithelial Cells; Fas Ligand Protein; fas Receptor; Female; Fish Oils; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Membrane Potential, Mitochondrial; Rats, Wistar; Signal Transduction | 2016 |
Preventative effect of celecoxib in dimethylbenz[a]anthracene-induced ovarian cancer in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Apoptosis; Carcinosarcoma; Celecoxib; Cell Cycle; Cyclooxygenase Inhibitors; Diet; Female; Ovarian Neoplasms; Rats; Rats, Wistar; Sarcoma | 2018 |
Effect of celecoxib on protein expression of FAK and Cx43 in DMBA induced rat tongue carcinoma cells.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Celecoxib; Connexin 43; Disease Models, Animal; Focal Adhesion Kinase 1; Injections, Intraperitoneal; Male; Rats; Rats, Sprague-Dawley; Tongue Neoplasms | 2019 |